Detailed Information on Publication Record
2024
The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia
PSENKOVA, Maria Bucek, Lucia HLAVINKOVA, Martin VISNANSKY, Dominik GREGA, Martina ONDRUSOVA et. al.Basic information
Original name
The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia
Authors
PSENKOVA, Maria Bucek (guarantor), Lucia HLAVINKOVA, Martin VISNANSKY, Dominik GREGA (703 Slovakia, belonging to the institution) and Martina ONDRUSOVA
Edition
Value in Health Regional Issues, AMSTERDAM, Elsevier, 2024, 2212-1099
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.000 in 2022
Organization unit
Faculty of Pharmacy
UT WoS
001117736600001
Keywords in English
checklist; guidelines; health economic evaluation.
Tags
International impact, Reviewed
Změněno: 15/1/2024 09:10, JUDr. Sabina Krejčiříková
Abstract
V originále
Objectives: We have developed a scientifically well-grounded, methodological, and reporting checklist for economic evaluation (EE) of medicines in the Slovak health technology assessment process, which serves as a supplement to the Methods: The checklist was developed using an iterative process in which items were generated and gradually added to the baseline checklist based on shortcomings identified in an analysis of Slovak EEs, using relevant published checklists, and Slovak, as well as international, methodological guidance that was identified in the systematic literature review. The selection of checklist recommendations, their clarity, and relevance to the Slovak setting were validated in the online Results: From the sample of 151 price and reimbursement submissions published between January 2018 and July 2021, almost half of them (n = 73) received at least 1 request from the Ministry of Healthcare to justify or modify the methodology used in the EE; and in 18 proceedings, a negative opinion was issued because of shortcomings identified in the EE. The 25-items preliminary checklist, resulting from an iterative working process, has been validated in an online survey conducted among members of ISPOR Chapter Slovakia. After incorporating relevant comments, the final proposal for the Slovak checklist consists of 55 recommendations. Conclusions: The research represented the first attempt to create a Slovak EE checklist, which serves as a part of ISPOR Slovakia pharmacoeconomic guidelines. Implementation of the checklist allows checking whether EE meets legislative and methodological requirements and thus helps in improving the appropriateness and standardization of EEs in Slovakia.